SEOM-TTCC clinical guideline in nasopharynx cancer (2021)

Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves...

Descripción completa

Detalles Bibliográficos
Autores principales: Rueda Domínguez, Antonio, Cirauqui, Beatriz, García Castaño, Almudena, Alvarez Cabellos, Ruth, Carral Maseda, Alberto, Castelo Fernández, Beatriz, Iglesias Rey, Leticia, Rubió-Casadevall, Jordi, Arrazubi, Virginia, Mesía, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986714/
https://www.ncbi.nlm.nih.gov/pubmed/35303267
http://dx.doi.org/10.1007/s12094-022-02814-x
_version_ 1784682590319411200
author Rueda Domínguez, Antonio
Cirauqui, Beatriz
García Castaño, Almudena
Alvarez Cabellos, Ruth
Carral Maseda, Alberto
Castelo Fernández, Beatriz
Iglesias Rey, Leticia
Rubió-Casadevall, Jordi
Arrazubi, Virginia
Mesía, Ricard
author_facet Rueda Domínguez, Antonio
Cirauqui, Beatriz
García Castaño, Almudena
Alvarez Cabellos, Ruth
Carral Maseda, Alberto
Castelo Fernández, Beatriz
Iglesias Rey, Leticia
Rubió-Casadevall, Jordi
Arrazubi, Virginia
Mesía, Ricard
author_sort Rueda Domínguez, Antonio
collection PubMed
description Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
format Online
Article
Text
id pubmed-8986714
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-89867142022-04-22 SEOM-TTCC clinical guideline in nasopharynx cancer (2021) Rueda Domínguez, Antonio Cirauqui, Beatriz García Castaño, Almudena Alvarez Cabellos, Ruth Carral Maseda, Alberto Castelo Fernández, Beatriz Iglesias Rey, Leticia Rubió-Casadevall, Jordi Arrazubi, Virginia Mesía, Ricard Clin Transl Oncol Clinical Guides in Oncology Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time. Springer International Publishing 2022-03-18 2022 /pmc/articles/PMC8986714/ /pubmed/35303267 http://dx.doi.org/10.1007/s12094-022-02814-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Clinical Guides in Oncology
Rueda Domínguez, Antonio
Cirauqui, Beatriz
García Castaño, Almudena
Alvarez Cabellos, Ruth
Carral Maseda, Alberto
Castelo Fernández, Beatriz
Iglesias Rey, Leticia
Rubió-Casadevall, Jordi
Arrazubi, Virginia
Mesía, Ricard
SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
title SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
title_full SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
title_fullStr SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
title_full_unstemmed SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
title_short SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
title_sort seom-ttcc clinical guideline in nasopharynx cancer (2021)
topic Clinical Guides in Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986714/
https://www.ncbi.nlm.nih.gov/pubmed/35303267
http://dx.doi.org/10.1007/s12094-022-02814-x
work_keys_str_mv AT ruedadominguezantonio seomttccclinicalguidelineinnasopharynxcancer2021
AT cirauquibeatriz seomttccclinicalguidelineinnasopharynxcancer2021
AT garciacastanoalmudena seomttccclinicalguidelineinnasopharynxcancer2021
AT alvarezcabellosruth seomttccclinicalguidelineinnasopharynxcancer2021
AT carralmasedaalberto seomttccclinicalguidelineinnasopharynxcancer2021
AT castelofernandezbeatriz seomttccclinicalguidelineinnasopharynxcancer2021
AT iglesiasreyleticia seomttccclinicalguidelineinnasopharynxcancer2021
AT rubiocasadevalljordi seomttccclinicalguidelineinnasopharynxcancer2021
AT arrazubivirginia seomttccclinicalguidelineinnasopharynxcancer2021
AT mesiaricard seomttccclinicalguidelineinnasopharynxcancer2021

Ejemplares similares